3.9 Article

Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses

Journal

MOLECULAR ENDOCRINOLOGY
Volume 21, Issue 1, Pages 77-88

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/me.2006-0225

Keywords

-

Funding

  1. NHLBI NIH HHS [P01 HL48743, R01 HL071745] Funding Source: Medline
  2. NIDDK NIH HHS [5P30DK046200] Funding Source: Medline
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL071745] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER

Ask authors/readers for more resources

beta-Carotene and its metabolites exert a broad range of effects, in part by regulating transcriptional responses through specific nuclear receptor activation. Symmetric cleavage of beta-carotene can yield 9-cis retinoic acid (9-cisRA), the natural ligand for the nuclear receptor RXR, the obligate heterodimeric partner for numerous nuclear receptor family members. A significant portion of beta-carotene can also undergo asymmetric cleavage to yield apocarotenals, a series of poorly understood naturally occurring molecules whose biologic role, including their transcriptional effects, remains essentially unknown. We show here that beta-apo-14'-carotenal (apo14), but not other structurally related apocarotenals, represses peroxisome proliferator-activated receptors (PPAR) and RXR activation and biologic responses induced by their respective agonists both in vitro and in vivo. During adipocyte differentiation, apo14 inhibited PPAR gamma target gene expression and adipogenesis, even in the presence of the potent PPAR gamma agonist BRL49653. Apo14 also suppressed known PPAR alpha responses, including target gene expression and its known antiinflammatory effects, but not if PPAR alpha agonist stimulation occurred before apo14 exposure and not in PPAR alpha-deficient cells or mice. Other apocarotenals tested had none of these effects. These data extend current views of beta-carotene metabolism to include specific apocarotenals as possible biologically active mediators and identify apo14 as a possible template for designing PPAR and RXR modulators and better understanding modulation of nuclear receptor activation. These results also suggest a novel model of molecular endocrinology in which metabolism of a parent compound, beta-carotene, may alternatively activate (9-cisRA) or inhibit (apo14) specific nuclear receptor responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available